Evidence map›Paper›PMID 25927016›Full record

ArticleTissue barriers2015

The role of intestinal epithelial barrier function in the development of NEC.

Melissa D Halpern, Patricia W Denning

Open access · bronzeAbstract read
In one paragraph

Article in Tissue barriers, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 111 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
111citing papers in PubMed, 3 pooled it
11.0field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

111 citing papers in PubMed, 3 syntheses or guidelines pooled it, 180 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Trial
  5. Trial
  6. Microplastics and Nanoplastics in Food: Dietary Toxicology Beyond Particle Counts.Comprehensive reviews in food science and food safety · 2026
    Review
  7. Article
  8. Chlorpyrifos and Chlorpyrifos-Oxon: A Widening Spectrum of Toxicity.International journal of molecular sciences · 2026
    Review
  9. Effects of specialized proresolving mediators on gut epithelial barrier in early life.The Journal of pharmacology and experimental therapeutics · 2026
    Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Review
  15. Article
  16. Article
  17. Tight junction proteins and intestinal health in preterm infants.Journal of neonatal-perinatal medicine · 2025
    Review
  18. Article
  19. Article
  20. Article

51 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 1 country.

Melissa D HalpernDepartment of Pediatrics; The University of Arizona ; Tucson, AZ USA.
Patricia W DenningDepartment of Pediatrics; Emory University School of Medicine ; Atlanta, GA USA.
Emory University · USUniversity of Arizona · US

Funding

Probiotics and Innate Intestinal DefenseR01HD059122 · NICHD · EMORY UNIVERSITY · PI DENNING, PATRICIA LANEE WEI · 2009 to 2013
$1.8M
Bile Acids as a Biomarker to Predict Development of Necrotizing EnterocolitisR21DK102058 · NIDDK · UNIVERSITY OF ARIZONA · PI HALPERN, MELISSA D · 2014 to 2015
$417k
NICHD NIH HHS R01 HD059122NIDDK NIH HHS R21 DK102058
6 · The paper itself

Abstract

The intestinal epithelial barrier plays an important role in maintaining host health. Breakdown of intestinal barrier function is known to play a role in many diseases such as infectious enteritis, idiopathic inflammatory bowel disease, and neonatal inflammatory bowel diseases. Recently, increasing research has demonstrated the importance of understanding how intestinal epithelial barrier function develops in the premature neonate in order to develop strategies to promote its maturation. Optimizing intestinal barrier function is thought to be key to preventing neonatal inflammatory bowel diseases such as necrotizing enterocolitis. In this review, we will first summarize the key components of the intestinal epithelial barrier, what is known about its development, and how this may explain NEC pathogenesis. Finally, we will review what therapeutic strategies may be used to promote optimal development of neonatal intestinal barrier function in order to reduce the incidence and severity of NEC.

Indexed as

AJ, adherens junctionsAJC, apical junction complexapical junctional complexBAs, bile acids; EGF, epidermal growth factorBb, Bifidobacterium bifidumBi, Bifidobacterium infantiscommensal bacteriaEPO, erythropoietin; IFNγ, interferon gammaIEL, intestinal epithelial lymphocytesintestinal epithelial barrierNEC, necrotizing enterocolitisNecrotizing enterocolitis (NEC)NICU, neonatal intensive care unitprematurityprobioticsTCRγδ, T-cell receptor gamma-deltaTGF-β, transforming growth factor-betatight junctionsTJ, tight junctionsTNFα, tumor necrosis factor alphaTPN, total parenteral nutrition

Identifiers

PMID25927016
PMCPMC4389790
OpenAlexW1927073913

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.